Showing 331-340 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| The master regulator transcription factor, Zbtb20, defines and controls a regulatory T cell subset that controls tissue inflammation | Virginia Commonwealth University | Derek Sant’Angelo | Cures | 01-September-2025 to 28-February-2027 | $382.996,65 |
| 3D bioprinted pancreatic tissue for beta cell replacement therapy | Wake Forest University Health Sciences | Amish Asthana | Cures | 01-March-2026 to 29-February-2028 | $599.990,14 |
| Combining Arteriovenous Bundle and ECM-Based Biomaterial Technologies to Induce Potent Neovascularization Following Islet Transplantation | Wake Forest University Health Sciences | Giuseppe Orlando | Cures | 01-April-2025 to 31-March-2027 | $248.692,00 |
| Enhancing Human Stem Cell-Derived Islet Survival and Function Using SA-PD-L1-Presenting Microgels | Washington University | Jeffrey Millman | Cures | 01-August-2024 to 31-July-2027 | $1.125.000,00 |
| Overcoming Production Barriers to Stem Cell-Islet Therapies Through Scalable Technologies | Washington University | Jeffrey Millman | Cures | 01-March-2026 to 29-February-2028 | $550.000,00 |
| Assess the antigenic profile in human T1D: from β-cell crinophagy to peripheral blood | Washington University | Xiaoxiao Wan | Cures | 01-April-2022 to 31-March-2027 | $750.000,00 |
| A Novel Ultra-Rapid Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-November-2025 to 31-October-2027 | $299.994,92 |
| Orally Delivered Glucose-Responsive Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-June-2024 to 31-May-2026 | $274.348,36 |
| Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity | Weill Medical College of Cornell University | Anna Ada Dattoli | Cures | 01-April-2026 to 31-March-2027 | $199.999,32 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600.000,00 |